Cargando…

Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis

BACKGROUND: Flexitrate, an innovative regional citrate anticoagulation (RCA) protocol, was compared to traditional RCA (tRCA) and Heparin anticoagulation protocols in intensive care patients treated with continuous renal replacement therapy (CRRT). METHODS: A single-center, retrospective, cohort stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lenga, Ilan, Hopman, Wilma M., O’Connell, Adam J., Hume, Francesca, Wei, Charles C. Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896713/ https://www.ncbi.nlm.nih.gov/pubmed/31805883 http://dx.doi.org/10.1186/s12882-019-1648-8

Ejemplares similares

Regional citrate anticoagulation (RCA) for continuous venovenous hemodiafiltration (CVVHDF): initial experience
por: Durão, M, et al.
Publicado: (2001)

Dynamics of the dosage of citrate-calciuminfusion regimens as anticoagulation in continuous venovenous hemodiafiltration
por: Marin Mateos, H, et al.
Publicado: (2015)

Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation
por: dos Santos, Thais Oliveira Claizoni, et al.
Publicado: (2023)

Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Park, Joon-Sung, et al.
Publicado: (2011)

Pilot study on a regional citrate anticoagulated continuous venovenous hemodiafiltration protocol with variable treatment dose
por: Slowinski, T, et al.
Publicado: (2010)

Blood epuration of middle molecules in continuous venovenous hemodiafiltration with regional citrate anticoagulation versus systemic heparinization
por: Nogier, MB, et al.
Publicado: (2009)

Regional citrate anticoagulation in high-volume continuous venovenous hemodialysis
por: Kalb, R, et al.
Publicado: (2011)

Validation of a Protocol for Continuous Hemodiafiltration with Regional Citrate Anticoagulation with Omni®
por: Whiting, Livia, et al.
Publicado: (2022)

Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid–base status and phosphate supplementation needs
por: Morabito, Santo, et al.
Publicado: (2013)

A Retrospective Review of the Use of Regional Citrate Anticoagulation in Continuous Venovenous Hemofiltration for Critically Ill Patients
por: Leung, Anne Kit-Hung, et al.
Publicado: (2013)

Pharmacokinetics and pharmacodynamics of esomeprazole and ranitidine during continuous venovenous hemodiafiltration
por: Fuhrmann, V, et al.
Publicado: (2013)

Cefiderocol Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemodiafiltration
por: Kobic, Emir, et al.
Publicado: (2021)

Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
por: Slowinski, Torsten, et al.
Publicado: (2015)

Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study
por: Schultheiß, Caroline, et al.
Publicado: (2012)

Impact of continuous veno-venous hemodiafiltration with regional citrate anticoagulation on the acid-base balance of critically ill patients
por: Passos, RH, et al.
Publicado: (2006)

Variability in Uremic Control during Continuous Venovenous Hemodiafiltration in Trauma Patients
por: Beitland, Sigrid, et al.
Publicado: (2012)

Role of early continuous venovenous hemodiafiltration in septic shock and multiorgan failure
por: Soliman, M, et al.
Publicado: (2010)

Pharmacokinetics of daptomycin in patients undergoing low-flow continuous venovenous hemodiafiltration
por: Ide, TI, et al.
Publicado: (2015)

Near-infrared spectroscopy parameters in patients undergoing continuous venovenous hemodiafiltration
por: Chaves, Renato Carneiro de Freitas, et al.
Publicado: (2019)

Effect of Phoxilium on prognostic predictors in patients undergoing continuous venovenous hemodiafiltration
por: Kim, Da Woon, et al.
Publicado: (2021)

Characteristics of continuous venovenous hemodiafiltration in the acute treatment of inherited metabolic disorders
por: Eminoğlu, Fatma Tuba, et al.
Publicado: (2021)

Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study
por: Yu, Yan, et al.
Publicado: (2020)

Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study
por: Yu, Yan, et al.
Publicado: (2020)

Citrate anticoagulation for continuous venovenous haemodiafiltration: the impact of a novel protocol on patients receiving therapy in one regional hospital
por: Highgate, J, et al.
Publicado: (2015)

Calcium Repletion and Regional Citrate Anticoagulation in Hemodialysis and Hemodiafiltration: Using Dialysate Calcium to Modify Hypocalcemia
por: Dorie, Justin R., et al.
Publicado: (2021)

Carbon dioxide elimination during continuous venovenous hemodiafiltration (CVVHD)-laboratory experiment
por: Ruzicka, J, et al.
Publicado: (2000)

Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients
por: Aguilar, Gerardo, et al.
Publicado: (2017)

Comparison of Sustained Hemodiafiltration with Acetate-Free Dialysate and Continuous Venovenous Hemodiafiltration for the Treatment of Critically Ill Patients with Acute Kidney Injury
por: Abe, Masanori, et al.
Publicado: (2011)

Atenolol and amlodipine combination overdose managed with continuous venovenous hemodiafiltration: A case report
por: Sandeep, P., et al.
Publicado: (2014)

Evaluation of optimized continuous venovenous hemodiafiltration therapy efficiency in severe burn patients with sepsis
por: Xu, Cheng, et al.
Publicado: (2014)

Acid base variables predict survival early in the course of treatment with continuous venovenous hemodiafiltration
por: Passos, Rogério da Hora, et al.
Publicado: (2018)

Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
por: Aguilar, Gerardo, et al.
Publicado: (2019)

Amino acid concentrations in serum, urine and dialysate/ultrafiltrate solutions of continuous venovenous hemodiafiltration patients
por: Lee, JM, et al.
Publicado: (2012)

Impedance cardiography in the estimation of hemodynamic and fluid status of coma patients during continuous venovenous hemodiafiltration
por: De Nicola, A, et al.
Publicado: (2009)

Effectiveness of continuous venovenous hemodiafiltration using a polymethylmethacrylate membrane hemofilter in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2008)

Continuous venovenous hemodiafiltration in the treatment of newborns with an inborn metabolic disease: a single center experience
por: AKDUMAN, Hasan, et al.
Publicado: (2020)

Hemoadsorption and continuous venovenous hemodiafiltration in the management of paraquat poisoning during pregnancy: A case report
por: Ballesteros, David A., et al.
Publicado: (2023)

Recurrent early filter clotting in regional citrate anticoagulated continuous venovenous hemodialysis due to undetected antibodies to heparin-platelet factor 4 complexes
por: Slowinski, T, et al.
Publicado: (2010)

Correction to: Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous venovenous hemofiltration
por: Jacobs, Rita, et al.
Publicado: (2020)

The combination of lactate and bicarbonate buffers in continuous venovenous hemodiafiltration and its impact on serum lactate levels and homeostasis
por: Balik, M, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_i6j0tnlbkv75mgvdvldejsdov0